Atlas Trials

Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC

Clinical trial NCT06815679 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06815679
Sponsor
Università degli Studi di Ferrara
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Respiratory FailurePneumonia
Start date
2025-03-01
Primary completion
2026-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.